epidural-related maternal fever
Conditions
Interventions
Sponsors
Shenzhen Longgang District Maternal and Child Healthcare Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Retrospective Study All parturients who received epidural labor analgesia from January 1, 2021, to December 31, 2024. 2. Prospective Study (1) ASA II–III; (2) Full-term pregnancy; (3) Parturients scheduled for vaginal delivery under epidural anesthesia.
Exclusion criteria
Exclusion criteria: 1. Patients with contraindications to painless delivery; 2. Patients who had a fever before delivery; 3. Patients with immunodeficiency diseases or autoimmune diseases; 4. Patients with any possible sterile or infectious inflammation; 5. Those who have taken antibiotics or hormone medications in the past month; 6. Other pregnant women deemed unsuitable for inclusion in the study by the researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CCL3/MiP-1 alpha;CCL4/MiP-1 beta;CD25/lL-2R alpha;GM-CSF;lFN-gamma;lL-1 beta;IL-2;IL-4;IL-5;IL-6;1L-8/CXCL8;IL-10;IL-12/IL-23 p40;IL-17/IL-17A;TNF-alpha;mRNA; | — |
Countries
China
Contacts
Public ContactZhao Yang
Shenzhen Longgang District Maternal and Child Healthcare Hospital
Outcome results
None listed